As the Skin Tightening Category Gets Louder, Leading Providers Are Choosing EVERESSE™ from Cartessa Aesthetics

Backed by differentiated monopolar RF technology, global scale and an exclusive North American partnership between Cartessa Aesthetics and CLASSYS, EVERESSE™ continues to gain traction among discerning aesthetic providers.

MELVILLE, N.Y., Sept. 16, 2026 /PRNewswire/ -- Cartessa Aesthetics, a leading North American aesthetic medical device company, announced strong business momentum for the first half of 2026, as the company continues to expand its technology portfolio and provider network across the U.S. and Canada.

The company's key growth drivers includes EVERESSE™. Known globally as Volnewmer, EVERESSE™ is a next-generation monopolar radiofrequency platform developed and manufactured by CLASSYS, a global leader in medical aesthetic technology, and exclusively commercialized in North America by Cartessa Aesthetics. EVERESSE has now surpassed 4,000 installations worldwide. Since its North American launch, an estimated 12,000+ EVERESSE treatments have been performed across the U.S. and Canada alone.

"The momentum we've seen this year thus far reflects both the strength of our portfolio and the trust we've built with providers," said Jill Later, Chief Marketing Officer and Head of Commercialization. "As practices and their patients become increasingly discerning about aesthetic technology, we're seeing demand shift towards clinically validated devices that combine meaningful results with a better overall treatment experience."

EVERESSE's momentum comes as the non-invasive skin-tightening category becomes increasingly competitive, with providers navigating a wide range of technologies and treatment options. As a result, leading practices are looking beyond category noise to prioritize technologies backed by differentiated engineering, clinical evidence and patient experience.

EVERESSE is powered by 6.78 MHz monopolar radiofrequency technology and is the only device that uses continuous energy delivery with continuous water cooling to maintain the radiofrequency energy output. This increases the consistency of results and overall energy accumulation while prioritizing patient comfort. To date, eleven clinical studies involving human subjects and third-party publications have been published globally evaluating EVERESSE/Volnewmer technology.

Most recently, a published study comparing continuous water-cooled monopolar RF technology with pulsed gas-cooled monopolar RF found that the continuous water-cooled system provided a more comfortable patient experience while producing greater or equivalent improvements across evaluated efficacy metrics, including greater improvements in skin density and reductions in pore size.

Most recently, Everesse has been adopted by leading aesthetic physicians and providers across North America, including dermatologists Dr. Ava Shamban, Dr. Marisa Garshick, Dr. Christopher Tomassian, Dr. Bertha Baum, and Dr. Jenny Liu, and continues to grow in popularity among discerning medspa owners and operators.

"Of all the radiofrequency and ultrasound skin tightening devices that I have used over 20 years, I find the Everesse device is the optimal combination of energy delivered in a manner that is tolerable to the patient, says Board Certified Dermatologist and Owner at Lupo Center, Dr.Mary Lupo. "Heating in such a way that patients can get maximum radiofrequency pulses, a comfortable experience, and results in as little as one treatment. Its versatility to use on the face as well as the body makes it a superior choice for non-surgical skin tightening."

EVERESSE has continued to build consumer and industry recognition alongside its growing adoption among providers. The award-winning treatment has generated significant media momentum, with Cartessa's organic media placements reaching approximately 430 million impressions. EVERESSE has also gained visibility among notable personalities, including Kat James, Kesha, Bryan Johnson, and Katherine McPhee Foster.

Beyond EVERESSE, Cartessa continued to expand its portfolio in the first half of 2026 with the U.S. and Canadian launch of DEKA's ONDA PRO, the Canadian expansion of IPL platforrm PRISMA and the U.S. launch of CLASSYS' QUADESSY.

For the remainder of 2026, the company will continue to focus on bringing differentiated, clinically supported technologies from leading global manufacturers to its growing network of aesthetic providers, while expanding consumer awareness of its leading treatment platforms.

About Cartessa Aesthetics

Cartessa Aesthetics is a leading North American aesthetic company focused on cutting-edge technology and industry-leading customer support. Thanks to an independent business model and established relationships with top global manufacturers, Cartessa's product portfolio offers true competitive advantages for practices and patients across every aesthetics category. Customers benefit from expertly vetted devices and end-to-end support to maximize clinical outcomes and return on investment.

SOURCE Cartessa Aesthetics